Chiltern posts record revenue in 2012

U.K. CRO Chiltern hauled in $137.5 million in fiscal 2012, good for 16.8% growth over the previous year. The company now employs about 1,600 people around the world, and CEO Jim Esinhart said he expects continued growth as Chiltern expands its market share among mid-tier CROs. Results

Suggested Articles

The money will be used to expand its footprint in both China and the U.S., including a new R&D operation in Boston.

Aetion has raised $50 million so far, and it plans to enhance its platform to support more complex therapeutic areas and expand its team.

Charles River partners with PathoQuest to offer clients NGS solutions for biologics viral contamination testing and cell-line genetic characterization.